Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2906 | 2784 | 42.6 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
2906 | 2 | SIGLEC//TREM2//TREM 1 | 2784 |
12766 | 1 | SIGLEC//CD22//SIALOADHESIN | 882 |
14945 | 1 | TREM2//TREM 1//NASU HAKOLA DISEASE | 740 |
16383 | 1 | LAIR 1//CD300A//ITIM | 656 |
22899 | 1 | CD200//CD200R//RP105 | 365 |
32315 | 1 | FCRL3//FCRL//FCRL3 GENE | 141 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SIGLEC | authKW | 876048 | 4% | 74% | 108 |
2 | TREM2 | authKW | 824472 | 3% | 85% | 88 |
3 | TREM 1 | authKW | 629021 | 2% | 83% | 69 |
4 | CD200 | authKW | 624859 | 3% | 64% | 89 |
5 | NASU HAKOLA DISEASE | authKW | 328990 | 1% | 100% | 30 |
6 | CD22 | authKW | 316348 | 2% | 42% | 69 |
7 | DAP12 | authKW | 272425 | 2% | 59% | 42 |
8 | TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 | authKW | 224633 | 1% | 79% | 26 |
9 | MEMBRANOUS LIPODYSTROPHY | authKW | 219823 | 1% | 95% | 21 |
10 | STREM 1 | authKW | 219570 | 1% | 69% | 29 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 23345 | 44% | 0% | 1225 |
2 | Biochemistry & Molecular Biology | 851 | 18% | 0% | 515 |
3 | Hematology | 655 | 5% | 0% | 152 |
4 | Cell Biology | 610 | 10% | 0% | 265 |
5 | Medicine, Research & Experimental | 470 | 6% | 0% | 167 |
6 | Neurosciences | 439 | 10% | 0% | 274 |
7 | Rheumatology | 348 | 2% | 0% | 65 |
8 | Pathology | 346 | 4% | 0% | 107 |
9 | Transplantation | 138 | 2% | 0% | 52 |
10 | Critical Care Medicine | 136 | 2% | 0% | 48 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | WELLCOME TRUST BIO DUNDEE | 77981 | 0% | 89% | 8 |
2 | WELLCOME TRUST BIO | 66582 | 2% | 11% | 53 |
3 | GLYCOBIOL TRAINING | 63717 | 1% | 14% | 41 |
4 | DEV CLIN IMMUNOL | 54713 | 1% | 18% | 27 |
5 | SERV TR IANTI ORGANO | 47668 | 0% | 43% | 10 |
6 | RECEPTOR CELL BIOL SECT | 45712 | 1% | 30% | 14 |
7 | PHYSIOL EXPT | 32899 | 0% | 100% | 3 |
8 | BIOCHEM HEIDELBERG | 30458 | 0% | 56% | 5 |
9 | NEURAL REGENERAT GRP | 28192 | 0% | 43% | 6 |
10 | MOL DEV IMMUNOL | 26112 | 0% | 26% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 9515 | 8% | 0% | 218 |
2 | EUROPEAN JOURNAL OF IMMUNOLOGY | 5774 | 3% | 1% | 84 |
3 | IMMUNOGENETICS | 4275 | 2% | 1% | 42 |
4 | HUMAN IMMUNOLOGY | 3538 | 1% | 1% | 39 |
5 | JOURNAL OF EXPERIMENTAL MEDICINE | 2719 | 2% | 0% | 56 |
6 | INTERNATIONAL IMMUNOLOGY | 2573 | 1% | 1% | 31 |
7 | GLYCOBIOLOGY | 2565 | 1% | 1% | 26 |
8 | NATURE IMMUNOLOGY | 2367 | 1% | 1% | 22 |
9 | DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY | 2359 | 1% | 1% | 28 |
10 | IMMUNITY | 2118 | 1% | 1% | 26 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIGLEC | 876048 | 4% | 74% | 108 | Search SIGLEC | Search SIGLEC |
2 | TREM2 | 824472 | 3% | 85% | 88 | Search TREM2 | Search TREM2 |
3 | TREM 1 | 629021 | 2% | 83% | 69 | Search TREM+1 | Search TREM+1 |
4 | CD200 | 624859 | 3% | 64% | 89 | Search CD200 | Search CD200 |
5 | NASU HAKOLA DISEASE | 328990 | 1% | 100% | 30 | Search NASU+HAKOLA+DISEASE | Search NASU+HAKOLA+DISEASE |
6 | CD22 | 316348 | 2% | 42% | 69 | Search CD22 | Search CD22 |
7 | DAP12 | 272425 | 2% | 59% | 42 | Search DAP12 | Search DAP12 |
8 | TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 | 224633 | 1% | 79% | 26 | Search TRIGGERING+RECEPTOR+EXPRESSED+ON+MYELOID+CELLS+1 | Search TRIGGERING+RECEPTOR+EXPRESSED+ON+MYELOID+CELLS+1 |
9 | MEMBRANOUS LIPODYSTROPHY | 219823 | 1% | 95% | 21 | Search MEMBRANOUS+LIPODYSTROPHY | Search MEMBRANOUS+LIPODYSTROPHY |
10 | STREM 1 | 219570 | 1% | 69% | 29 | Search STREM+1 | Search STREM+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VARKI, A , ANGATA, T , (2006) SIGLECS - THE MAJOR SUBFAMILY OF I-TYPE LECTINS.GLYCOBIOLOGY. VOL. 16. ISSUE 1. P. 1R-27R | 177 | 75% | 187 |
2 | CROCKER, PR , PAULSON, JC , VARKI, A , (2007) SIGLECS AND THEIR ROLES IN THE IMMUNE SYSTEM.NATURE REVIEWS IMMUNOLOGY. VOL. 7. ISSUE 4. P. 255-266 | 99 | 81% | 591 |
3 | MACAULEY, MS , CROCKER, PR , PAULSON, JC , (2014) SIGLEC-MEDIATED REGULATION OF IMMUNE CELL FUNCTION IN DISEASE.NATURE REVIEWS IMMUNOLOGY. VOL. 14. ISSUE 10. P. 653 -666 | 100 | 72% | 76 |
4 | PILLAI, S , NETRAVALI, IA , CARIAPPA, A , MATTOO, H , (2012) SIGLECS AND IMMUNE REGULATION.ANNUAL REVIEW OF IMMUNOLOGY, VOL 30. VOL. 30. ISSUE . P. 357 -392 | 117 | 73% | 93 |
5 | BOSCO, MC , RAGGI, F , VARESIO, L , (2016) THERAPEUTIC POTENTIAL OF TARGETING TREM-1 IN INFLAMMATORY DISEASES AND CANCER.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 41. P. 6209 -6233 | 136 | 66% | 1 |
6 | PAULSON, JC , MACAULEY, MS , KAWASAKI, N , (2012) SIGLECS AS SENSORS OF SELF IN INNATE AND ADAPTIVE IMMUNE RESPONSES.GLYCOBIOLOGY OF THE IMMUNE RESPONSE. VOL. 1253. ISSUE . P. 37-48 | 101 | 78% | 27 |
7 | VON GUNTEN, S , BOCHNER, BS , (2008) BASIC AND CLINICAL IMMUNOLOGY OF SIGLECS.YEAR IN IMMUNOLOGY 2008. VOL. 1143. ISSUE . P. 61-82 | 107 | 71% | 53 |
8 | KANG, XL , KIM, J , DENG, M , JOHN, S , CHEN, HY , WU, GJ , PHAN, H , ZHANG, CC , (2016) INHIBITORY LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTORS: IMMUNE CHECKPOINT PROTEINS AND TUMOR SUSTAINING FACTORS.CELL CYCLE. VOL. 15. ISSUE 1. P. 25 -40 | 104 | 57% | 2 |
9 | MAGESH, S , ANDO, H , TSUBATA, T , ISHIDA, H , KISO, M , (2011) HIGH-AFFINITY LIGANDS OF SIGLEC RECEPTORS AND THEIR THERAPEUTIC POTENTIALS.CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 23. P. 3537-3550 | 97 | 75% | 8 |
10 | NITSCHKE, L , (2009) CD22 AND SIGLEC-G: B-CELL INHIBITORY RECEPTORS WITH DISTINCT FUNCTIONS.IMMUNOLOGICAL REVIEWS. VOL. 230. ISSUE . P. 128-143 | 84 | 74% | 62 |
Classes with closest relation at Level 2 |